Excel Venture dedicates $125M fund to life sciences firms

07/8/2009 | Boston Globe (tiered subscription model), The

Excel Venture Management has unveiled a $125 million fund that it will invest in early- to late-stage life sciences companies. Aileron Therapeutics, which works on "Stapled Peptides" that home in on intracellular protein-protein interactions, is among the three firms that secured financing from the Excel Medical Fund.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA